Clinical Trial Update: Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk [NA]

View source ↗

Summary

A clinical trial update indicates lidocaine may reduce postoperative recurrence and metastasis risk in non-small cell lung cancer, though the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: Non-Small Cell Lung Cancer, Recurrence | NA | Status: NOT_YET_RECRUITING